A carregar...
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Chronic hepatitis B (CHB) remains a challenging global health problem, with nearly one million related deaths per year. Nucleos(t)ide analogue (NA) treatment suppresses viral replication but does not provide complete cure of the hepatitis B virus (HBV) infection. The accepted endpoint for therapy is...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937201/ https://ncbi.nlm.nih.gov/pubmed/29740199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i17.1825 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|